These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6390133)

  • 1. [Human insulin. Receptor affinity, acute effects and long-term treatment].
    Adezati L; Andraghetti G; Boeri D; Canepa A; Carta G; Cordera R; Falzetti G; Gherzi R; Maiello M; Odetti P
    Minerva Endocrinol; 1984; 9(2):181-92. PubMed ID: 6390133
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin binding to erythrocytes in insulin dependent diabetics with different insulin requirement and insulin antibody titre.
    Turco GL; Bruni B; Brossa C; D'Alberto M; Grassi G; Gamba Ansaldi S; Censon A
    J Nucl Med Allied Sci; 1984; 28(3):149-55. PubMed ID: 6397582
    [No Abstract]   [Full Text] [Related]  

  • 3. [Binding of insulin to erythrocytes before and after transfer from swine to biosynthetic human insulin. Studies in children and adolescents with type I diabetes].
    Zick R; Hürter P; Meyer B; von Schütz W; Holle W; Dwenger A; Mitzkat HJ
    MMW Munch Med Wochenschr; 1983 May; Suppl 1():S97-100. PubMed ID: 6408442
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythrocyte insulin binding in insulin-dependent diabetes mellitus: lack of relationship to duration and control of diabetes in children and adolescents.
    Kappy MS; Plotnick LP; Findlay JC; Kayne RD
    Pediatrics; 1980 Sep; 66(3):385-90. PubMed ID: 6999446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of insulin-erythrocyte binding in children with diabetes at diagnosis and after insulin therapy].
    Pedone A; Somaschini M; Meschi F; Beccaria L; Bianchi C
    Minerva Pediatr; 1984 May; 36(9):465-9. PubMed ID: 6381980
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythrocyte insulin receptors in non-insulin-dependent diabetics before and after treatment.
    Tanggo Y
    Hiroshima J Med Sci; 1985 Sep; 34(3):331-45. PubMed ID: 3905718
    [No Abstract]   [Full Text] [Related]  

  • 7. [Insulin cell receptors in diabetes caused by pancreatitis].
    Frati-Munari AC; Rodríguez-Rodríguez J; Altamirano P
    Arch Invest Med (Mex); 1987; 18(2):157-66. PubMed ID: 3310946
    [No Abstract]   [Full Text] [Related]  

  • 8. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin].
    Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P
    Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of diabetics with human-type insulin].
    Bucalossi A; Petruzzi E
    Minerva Endocrinol; 1984; 9(2):193-5. PubMed ID: 6390134
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of circulating anti-insulin antibodies on the kinetics of injected insulin in type I diabetes mellitus].
    Bolli GB; De Feo P; Perriello G; Ventura MM; De Cosmo S; Calafiore R; Pietropaolo M; Basta G; Lolli C; Batta M
    Recenti Prog Med; 1985 Jan; 76(1):2-5. PubMed ID: 3887513
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of highly purified semi-synthetic insulin and highly purified porcine insulin in the treatment of type I diabetes: interim report of a multi-centre randomised single blind study.
    Birtwell AJ; Owens DR; Jones IR; Hayes TM; Beale DJ; el-Shaboury AH; Arora P; Reeves WG
    Diabete Metab; 1984 Dec; 10(5):295-8. PubMed ID: 6397365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte insulin receptor abnormalities.
    Susheela L; Ramachandran A; Mohan V; Sheeja ; Viswanathan M
    J Assoc Physicians India; 1987 May; 35(5):337-9. PubMed ID: 3320021
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulin receptor interactions and metabolic effects of "essential" phospholipids in diabetes mellitus].
    Mikaelian NP; Kniazev IuA; Maksina AG; Mikaelian EP
    Biull Eksp Biol Med; 1994 Oct; 118(10):388-92. PubMed ID: 7865816
    [No Abstract]   [Full Text] [Related]  

  • 14. Feasibility and efficacy of long-term treatment by continuous subcutaneous insulin infusion (CSII) in insulin-dependent diabetes.
    Van Ballegooie E; Reitsma WD; Sluiter WJ; Doorenbos H
    Neth J Med; 1984; 27(5):185-92. PubMed ID: 6427640
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on insulin resistance and insulin receptor binding to erythrocytes in childhood obesity and diabetes mellitus (author's transl)].
    Asayama K; Amamiya S; Shinohara O; Ichimura K; Kusano S
    Horumon To Rinsho; 1981 Feb; 29(2):185-90. PubMed ID: 7261436
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of glyburide on metabolic control and insulin binding in insulin-dependent diabetes mellitus.
    Goldman J; Tamayo RC; Whitehouse FW; Kahkonen DM
    Diabetes Care; 1984; 7 Suppl 1():106-12. PubMed ID: 6428843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin-receptor interaction in Cushing's syndrome].
    Pallardo Sánchez LF; Grande Aragón C; López López J; Guerrero Martínez E; Albero Gamboa R; Cerdán Vallejo A
    Rev Clin Esp; 1986 Jun; 179(1):18-21. PubMed ID: 3526431
    [No Abstract]   [Full Text] [Related]  

  • 18. [24-hour profile of intermediate metabolites in diabetic patients treated with human insulin (HM, Novo)].
    Parenti M; Pasquali R; Biso P; Casadio G; Mattioli L; Babini AC; Melchionda N
    Minerva Endocrinol; 1984; 9(2):141-5. PubMed ID: 6390128
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma trivalent chromium, glucose tolerance and insulin secretion in juvenile- and adult-onset diabetes mellitus.
    Gedik O; Unal S; Koray Z
    Isr J Med Sci; 1980 Aug; 16(8):563-5. PubMed ID: 6998922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HDL cholesterol and insulin therapy in type 1 diabetes].
    Manicardi V; Bonora E; Coscelli C
    Minerva Endocrinol; 1984; 9(2):275-8. PubMed ID: 6390139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.